Better Medicines for Children's Project launched
April 15, 2010
Accra, April 15, GNA - Mr. James Ohemeng Kyei, Chief Pharmacist of Ministry of Health, said that the use of adult medication for children was an unacceptable practice that should not be encouraged.
He said that "Children are not small adults and the safety and suitability of the medicines should not be determined by adult size", according to the International Paediatric Association.
Mr. Kyei was speaking at the launch of the Better Medicines for Children's Project, in Accra on Thursday.
He said that in the absence of child-friendly liquid oral formulation, providers and parents some times used fractions of adult dosage forms or crush tablets or add portion of the content of capsules to infant feed.
Mr. Kyei said that "This is unacceptable and providers and guardians should desist form the practice".
The National Drugs Programme and Ministry of Health would assess the current situation of children's medicine in the country with support from the World Health Organisation to improve access to life saving medicines for children, according to the Programme Manager, Mrs Martha Gyansah Lutterodt
The project would improve access to child specific medicines in the sector and their rational use.
It would determine if amoxicillin, zinc, anti malaria and other key medicines for children were available in appropriate dosage forms in health facilities across Ghana and work with health care workers and paediatricians to meet required standards.
The Project would also work with pharmaceutical manufacturers to identify medicines that should be available to treat the major disease in children particularly pneumonia, diarrhoea and malaria and promote their availability as well as ensure that national treatment guidelines for the diseases were up to date on the best scientific evidence available.
In a speech read on behalf on his behalf, the Minister of Health, Dr. Benjamin Kunbuor said the Project among other things aimed at reviewing the current level of use of child specific medicines in Ghana, build capacity in evidence-based policy decision making.
He said in response to the reduction of Child mortality as expressed in the Millennium Development Goals (4,5, and 6), Ghana in 2007 developed a child health policy with a goal to reduce it from 111 death per 1000 births in 2006 to 40 death per 1000 live births by 2015.
Dr. Kunbuor said that child specific medicines are those manufactured to suit the age, physical condition and body weight of the child taking it.
He said that the Project must become a reality because children especially neonates differ from adult in their response to medicines.
Dr. Kunbuor said that the Project should focus on appropriate formulation for children in terms of efficacy and their pharmaco-economic context and also concentrate on adverse reaction monitoring among children.
Dr. Susan Hill, a representative from WHO headquarters, said the 'make medicine child size' was a global campaign launched in December 2007 and spearheaded by WHO to raise awareness and accelerate action to address the need for improved availability and access to safe child-specific medicines for all children under 12.
One of the challenges in developing medicines for children was the lack of knowledge about the effect certain medicines could have on children, she said, and noted that this was largely because fewer clinical trials were conducted in children than adults.
Dr, Hill called for fixed dose combination and flexible oral dosage medicines and a keen interest in the supply chain to ensure that the right thing was done.
Dr. Daniel Kertesz, WHO Representative in Ghana, said many countries including Ghana were making progress in respect with the MDGs but still needed to do more in intervention for children because they still die from preventable diseases such malaria and Diarrhoea.
This, he said, called for availability of medicines in the right dosage, quality and at the right place to help reduce child mortality.
GNA